Fernand Labrie
97Patents
25h-index
34Co-inventors
88Inventor score
Filing activity: Feb 23, 1983 → Nov 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5434146A | Controlled release systems and low dose androgens | Emerging Cross-Sectional Technologies | 121 | Expired |
| US5395842A | Anti-estrogenic compounds and compositions | Chemistry; Metallurgy | 119 | Expired |
| US4472382A | Treatment method | Emerging Cross-Sectional Technologies | 95 | Expired |
| US5861387A | Controlled release systems and low dose androgens | Emerging Cross-Sectional Technologies | 92 | Expired |
| US5541172A | Controlled release systems and low dose androgens | Emerging Cross-Sectional Technologies | 76 | Expired |
| US8268806B2 | Pharmaceutical compositions | Human Necessities | 59 | Active |
| US4760053A | Combination therapy for selected sex steroid dependent cancers | Emerging Cross-Sectional Technologies | 58 | Expired |
| US7429576B2 | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors | Human Necessities | 55 | Expired |
| US5362720A | Methods of treating or preventing breast or endometrial cancer with low dose non-masculinizing androgenic compounds | Human Necessities | 54 | Expired |
| US6710059B1 | Methods of treating and/or suppressing weight gain | Human Necessities | 53 | Expired |
| US4659695A | Method of treatment of prostate cancer | Human Necessities | 53 | Expired |
| US5372996A | Method of treatment of androgen-related diseases | Chemistry; Metallurgy | 48 | Expired |
| US5550107A | Combination therapy for the treatment of estrogen-sensitive disease | Human Necessities | 46 | Expired |
| US5817649A | Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia | Human Necessities | 42 | Expired |
| US4775660A | Treatment of breast cancer by combination therapy | Emerging Cross-Sectional Technologies | 39 | Expired |
| US5393785A | Therapeutic antiestrogens | Chemistry; Metallurgy | 38 | Expired |
| US5728688A | Therapeutic methods and delivery systems utilizing sex steroid precursors | Chemistry; Metallurgy | 38 | Expired |
| US6465445B1 | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors | Human Necessities | 37 | Expired |
| US4775661A | Combination therapy for treatment of female breast cancer | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5840735A | Sex steroid activity inhibitors | Chemistry; Metallurgy | 28 | Expired |
| US4666885A | Combination therapy for treatment of female breast cancer | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5595985A | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia | Chemistry; Metallurgy | 27 | Expired |
| US5364847A | Inhibitors of sex steroid biosynthesis and methods for their production and use | Chemistry; Metallurgy | 26 | Expired |
| US5846960A | Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds | Human Necessities | 26 | Expired |
| US5776923A | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone | Chemistry; Metallurgy | 25 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.